Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/35799
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | MOREIRA, Airton Mota | |
dc.contributor.author | ASSIS, Andre Moreira de | |
dc.contributor.author | CARNEVALE, Francisco Cesar | |
dc.contributor.author | OLIVEIRA, Daniel Simoes | |
dc.contributor.author | ANTUNES, Alberto Azoubel | |
dc.date.accessioned | 2020-06-01T14:45:59Z | - |
dc.date.available | 2020-06-01T14:45:59Z | - |
dc.date.issued | 2020 | |
dc.identifier.citation | CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, v.43, n.4, p.613-619, 2020 | |
dc.identifier.issn | 0174-1551 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/35799 | - |
dc.description.abstract | Aim The aim of this study is to compare the improvements in irritative versus obstructive symptoms of the International Prostate Symptom Score (IPSS) after prostatic artery embolization (PAE) in patients with benign prostatic hyperplasia (BPH). Materials and Methods Between 2010 and 2018, 186 patients underwent PAE in a single center and 174 patients were retrospectively selected. The inclusion criteria were symptoms due to BPH, refractory to pharmacological treatment and IPSS >= 8. The mean age of the patients was 63.7 +/- 7.2 years, the mean prostate volume 89.5 +/- 42.5 cm(3), and the mean IPSS 19.0 +/- 6.2 points. Patient data were reviewed at baseline, 3, 12 and 24 months and compared using the ANOVA mixed models and the Tukey's multiple comparison test. Results Obstructive subscores dropped more significantly than irritative subscores (p < 0.0001). The mean decrease in each IPSS item was frequency 2.4 (83%); urgency 0.8 (87%); nocturia 1.3 (49%); incomplete emptying 2.6 (83%); intermittency 2.3 (91%); weak stream 2.9 (82%); straining 1.6 (91%). The area under the curve for baseline obstructive scores was 0.7 (p = 0.006) and 0.59 (p = 0.182) for irritative scores. The most common BPH clinical manifestations include irritative and/or obstructive symptoms, the latter usually more prevalent. The IPSS drop observed after PAE suggests that it acts predominantly over obstructive symptoms (p < 0.0001). Conclusion Although a predominant improvement in obstructive symptoms may be observed after PAE, nocturia complaints may require special attention. The severity of baseline obstructive symptoms may significantly predict clinical outcomes. | eng |
dc.language.iso | eng | |
dc.publisher | SPRINGER | eng |
dc.relation.ispartof | Cardiovascular and Interventional Radiology | |
dc.rights | restrictedAccess | eng |
dc.subject | Benign prostatic hyperplasia | eng |
dc.subject | Lower urinary tract symptoms | eng |
dc.subject | International prostate symptom score | eng |
dc.subject | Embolization | eng |
dc.subject | Prostate artery embolization | eng |
dc.subject | Imaging | eng |
dc.subject | Interventional radiology | eng |
dc.subject.other | bladder outlet obstruction | eng |
dc.subject.other | hyperplasia | eng |
dc.title | Improvements in Irritative Versus Obstructive Symptoms of the International Prostate Symptom Score After Prostatic Artery Embolization in 174 Patients, in a Single Center | eng |
dc.type | article | eng |
dc.rights.holder | Copyright SPRINGER | eng |
dc.identifier.doi | 10.1007/s00270-019-02398-0 | |
dc.identifier.pmid | 31897620 | |
dc.subject.wos | Cardiac & Cardiovascular Systems | eng |
dc.subject.wos | Radiology, Nuclear Medicine & Medical Imaging | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
hcfmusp.description.beginpage | 613 | |
hcfmusp.description.endpage | 619 | |
hcfmusp.description.issue | 4 | |
hcfmusp.description.volume | 43 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.id | WOS:000505389300004 | |
hcfmusp.origem.id | 2-s2.0-85077538057 | |
hcfmusp.publisher.city | NEW YORK | eng |
hcfmusp.publisher.country | UNITED STATES | eng |
hcfmusp.relation.reference | Agresti A., 1990, CATEGORICAL DATA ANA | eng |
hcfmusp.relation.reference | BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5 | eng |
hcfmusp.relation.reference | Cockett AT, 1993, 2 INT CONS BEN PROST, P553 | eng |
hcfmusp.relation.reference | Conover WJ, 1980, PRACTICAL NONPARAMET | eng |
hcfmusp.relation.reference | de Assis AM, 2015, J VASC INTERV RADIOL, V26, P87, DOI 10.1016/j.jvir.2014.10.012 | eng |
hcfmusp.relation.reference | de la Rosette JJMCH, 1998, NEUROUROL URODYNAM, V17, P99, DOI 10.1002/(SICI)1520-6777(1998)17:2<99::AID-NAU3>3.0.CO;2-7 | eng |
hcfmusp.relation.reference | Dmochowski Roger R, 2005, Rev Urol, V7 Suppl 6, pS3 | eng |
hcfmusp.relation.reference | Kuang M, 2017, CARDIOVASC INTER RAD, V40, P655, DOI 10.1007/s00270-016-1539-3 | eng |
hcfmusp.relation.reference | Liao C-H, 2010, INCONTINENCE PELVIC, V4, P39 | eng |
hcfmusp.relation.reference | Maclean D, 2020, CARDIOVASC INTER RAD, V43, P23, DOI 10.1007/s00270-019-02298-3 | eng |
hcfmusp.relation.reference | Madersbacher S, 1999, NEUROUROL URODYNAM, V18, P173, DOI 10.1002/(SICI)1520-6777(1999)18:3<173::AID-NAU3>3.3.CO;2-D | eng |
hcfmusp.relation.reference | Malling B, 2019, EUR RADIOL, V29, P287, DOI 10.1007/s00330-018-5564-2 | eng |
hcfmusp.relation.reference | McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074 | eng |
hcfmusp.relation.reference | NETER J, 1990, [No title captured] | eng |
hcfmusp.relation.reference | Oelke M, 2008, EUR UROL, V54, P419, DOI 10.1016/j.eururo.2008.02.017 | eng |
hcfmusp.relation.reference | Pisco JM, 2013, EUR RADIOL, V23, P2561, DOI 10.1007/s00330-012-2714-9 | eng |
hcfmusp.relation.reference | Ray AF, 2018, BJU INT, V122, P270, DOI 10.1111/bju.14249 | eng |
hcfmusp.relation.reference | Rosier Peter, 2019, F1000Res, V8, DOI 10.12688/f1000research.16120.1 | eng |
hcfmusp.relation.reference | Sun F, 2008, RADIOLOGY, V246, P783, DOI 10.1148/radiol.2463070647 | eng |
hcfmusp.relation.reference | Uflacker A, 2016, J VASC INTERV RADIOL, V27, P1686, DOI 10.1016/j.jvir.2016.08.004 | eng |
hcfmusp.relation.reference | Wang MQ, 2016, WORLD J UROL, V34, P1275, DOI 10.1007/s00345-016-1771-0 | eng |
hcfmusp.relation.reference | Winer BJ, 1971, STAT PRINCIPLES EXPT | eng |
dc.description.index | MEDLINE | eng |
dc.identifier.eissn | 1432-086X | |
hcfmusp.citation.scopus | 6 | - |
hcfmusp.scopus.lastupdate | 2024-03-29 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MCG Artigos e Materiais de Revistas Científicas - HC/ICESP Artigos e Materiais de Revistas Científicas - HC/InRad Artigos e Materiais de Revistas Científicas - LIM/55 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_MOREIRA_Improvements_in_Irritative_Versus_Obstructive_Symptoms_of_the_2020.PDF Restricted Access | publishedVersion (English) | 557.59 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.